Literature DB >> 11316772

Developmental regulation of vascular endothelial growth/permeability factor messenger ribonucleic acid levels in and vascularization of the villous placenta during baboon pregnancy.

V A Hildebrandt1, J S Babischkin, R D Koos, G J Pepe, E D Albrecht.   

Abstract

Vascular endothelial growth/permeability factor (VEG/PF) has an important role in angiogenesis; however, very little is known about the developmental regulation of VEG/PF and the vascular system within the placenta during human pregnancy. In the present study, therefore, a developmental approach was used in the baboon to determine the placental source of VEG/PF and its fms-like tyrosine kinase (flt-1) and kinase-insert domain containing (KDR/flk-1) receptors, and whether the rise in estrogen with advancing pregnancy was associated with a corresponding increase in placental VEG/PF expression and vascularization. VEG/PF messenger RNA (mRNA) levels were determined by competitive RT-PCR in villous cell fractions isolated by Percoll gradient centrifugation from placentas obtained on days 45 and 54 (very early), 60 (early), 100 (mid), and 165-170 (late) of baboon pregnancy (term = 184 days). Maternal peripheral serum estradiol increased from very low concentrations early in gestation (0.15-0.20 ng/ml) to an early surge of over 2.5 ng/ml on days 60-85, and peak levels of 4-6 ng/ml late in baboon pregnancy. VEG/PF mRNA was expressed in low level in the syncytiotrophoblast (<2,000 attomol/microgram total RNA), and values in this fraction did not change significantly with advancing gestation. VEG/PF mRNA expression was slightly greater in the inner villous core cell fraction; however, levels decreased (P < 0.05) between early and late gestation. Cytotrophoblasts were a major source of VEG/PF mRNA and levels increased (P < 0.01) from 3,631 +/- 844 attomol/microgram total RNA on day 45 to 25,807 +/- 5,873 attomol/microgram total RNA on day 170. VEG/PF protein expression determined by immunocytochemistry was abundant in cytotrophoblasts and lower in the syncytiotrophoblast and inner villous core cells. The flt-1 and KDR/flk-1 receptors were expressed in the vascular endothelial cells of the baboon villous placenta. The percentage of villous placenta occupied by blood vessels and the number of vessels/mm(2) villous tissue, determined by image analysis, progressively increased (P < 0.001; r = 0.97) from 3.4 +/- 0.2% and 447 +/- 29, respectively, on day 54 to 15.9 +/- 0.9% and 1,375 +/- 71, respectively, on day 170. In summary, the present study shows that villous cytotrophoblasts were a major source of VEG/PF mRNA and protein in the baboon villous placenta, and that cytotrophoblast VEG/PF mRNA levels and vascularization of the villous placenta closely paralleled the increase in estradiol concentrations of advancing pregnancy. These results are consistent with the concept that estrogen has an important role in establishing the new vascular system within the developing placenta during primate pregnancy and that VEG/PF mediates this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316772     DOI: 10.1210/endo.142.5.8174

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Angiogenesis in the female reproductive organs: pathological implications.

Authors:  Lawrence P Reynolds; Anna T Grazul-Bilska; Dale A Redmer
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

2.  Differential expression of placental villous angiopoietin-1 and -2 during early, mid and late baboon pregnancy.

Authors:  J S Babischkin; D L Suresch; G J Pepe; E D Albrecht
Journal:  Placenta       Date:  2006-04-21       Impact factor: 3.481

Review 3.  Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors:  Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 4.  Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy.

Authors:  Eugene D Albrecht; Gerald J Pepe
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

5.  Suppression of trophoblast uterine spiral artery remodeling by estrogen during baboon pregnancy: impact on uterine and fetal blood flow dynamics.

Authors:  Graham W Aberdeen; Thomas W Bonagura; Chris R Harman; Gerald J Pepe; Eugene D Albrecht
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

6.  Regulation of expression and localisation of the Na+/H+ exchanger (NHE) 3 and the NHE regulatory factor 2 in baboon placental syncytiotrophoblast by oestrogen.

Authors:  G J Pepe; M G Burch; E D Albrecht
Journal:  Placenta       Date:  2007-03-02       Impact factor: 3.481

7.  Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy.

Authors:  Eugene D Albrecht; Jeffery S Babischkin; Gerald J Pepe
Journal:  Mol Reprod Dev       Date:  2008-03       Impact factor: 2.609

8.  Placental villous vascular endothelial growth factor expression and vascularization after estrogen suppression during the last two-thirds of baboon pregnancy.

Authors:  Victoria A Robb; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

9.  The sphingosine 1-phosphate (S1P) signaling pathway is regulated during pregnancy in sheep.

Authors:  Kathrin A Dunlap; Hyeong-il Kwak; Robert C Burghardt; Fuller W Bazer; Ronald R Magness; Greg A Johnson; Kayla J Bayless
Journal:  Biol Reprod       Date:  2010-01-27       Impact factor: 4.285

10.  Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations.

Authors:  Rossella Sorice; Daniela Ruggiero; Teresa Nutile; Mario Aversano; Lotte Husemoen; Allan Linneberg; Catherine Bourgain; Anne-Louise Leutenegger; Marina Ciullo
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.